Table 1.

PICO elements used to determine studies eligible for inclusion within results of this review

Element	Focus
Population	Adult patients with early/resectable NSCLC (stage I–III) in the locoregional recurrence health state
Interventions/comparators	● Atezolizumab ● Pemetrexed ● Nab-paclitaxel ● Gemcitabine ● Vinorelbine ● Nivolumab ● Durvalumab ● Cemiplimab ● Avelumab ● Tegafur ± uracil (UFT) ● Osimertinib	● Pembrolizumab ● Erlotinib ● Cisplatin-based chemotherapy ● Carboplatin-based chemotherapy ● Gefitinib ● Afatinib ● Docetaxel ● Radiotherapy ● Best supportive care ● Etoposide ● Surgery
Outcomes	● Treatment patterns in locoregional recurrence (including palliative and supportive care) ● Survival outcomes for locoregional recurrence
Study design	Prospective and retrospective observational studies

QoL quality of life